ASCO 2019 | Stage IV melanoma: Frontline options

Paolo Ascierto

Paolo Ascierto, MD, of the National Tumor Institute, Milan, Italy discusses the options clinicians and patients have in the frontline setting for stage IV melanoma at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video